Biochemical markers in saliva of patients with oral squamous cell carcinoma

Asian Pacific Journal of Tropical Disease

Volumn 4, Issue S1, 2014, Pages

  Chianeh, Yousef Rezaei ^a   Prabhu, Krishnananda ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Head and neck squamous cell carcinoma (HNSCC); Oral cancer; Salivary biomarkers; Tumor microenvironment (TME)

Indexed keywords

ALBUMIN; AMYLASE; BINDING PROTEIN; BIOCHEMICAL MARKER; CA 125 ANTIGEN; CALCIUM BINDING PROTEIN; CATALASE; CD59 ANTIGEN; COFILIN 1; DNA; ENDOTHELIN 1; FIBRIN; GLUTATHIONE; HERMES ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MAC 2 BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PREALBUMIN; PROFILIN; PROTEIN S 100; S100 CALCIUM BINDING PROTEIN; TELOMERASE; TISSUE POLYPEPTIDE ANTIGEN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; CANCER DIAGNOSIS; HUMAN; MITOSIS; MOLECULAR PATHOLOGY; MOUTH FLORA; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SALIVA; SALIVA ANALYSIS; SALIVARY EXCRETION; SALIVATION; STEM CELL; TROPISM;

EID: 84893487841     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(14)60412-6     Document Type: Article

References (97)

1. Chianeh YJ, Manjunath R, Prabhu K, Fernandes D, Vidyasagar M, Kamath A Protein thiols and butryrylcholinestrase in saliva of oral cancer patients. Indian J Clin Biochem 2013, 10.1007/s12291-013-0352-x.
2. Hofman LF Human saliva as a diagnostic specimen. J Nutr 2001, 131:1621S-1625S.
3. Kaufman E, Lamster IB The diagnostic applications of saliva: a review. Crit Rev Oral Biol Med 2002, 13:197-212.
4. Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C Diagnostic potential of saliva: current state and future applications. Clin Chem 2011, 57(5):675-687.
5. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Reboiras-Lopez MD, Gandara Rey JM, Garcia-Garcia A Genetic and molecular alterations associated with oral squamous cell cancer (Review). Oncol Rep 2009, 22:1277-1282.
6. Duvvuri U, Myers JN Cancer of the head and neck is the sixth most common cancer worldwide. Curr Probl Surg 2009, 46:114-117.
7. Ragin CC, Modugno F, Gollin SM The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 2007, 86:104-114.
8. Abrahao AC, Bonelli BV, Nunes FD, Dias EP, Cabral MG Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders. Braz Oral Res 2011, 25(1):34-41.
9. Mendes SO, Dos Santos M, Peterle GT, Maia Lde L, Stur E, Agostini LP, et al. HIF-1alpha expression profile in intratumoral and peritumoral inflammatory cells as a prognostic marker for squamous cell carcinoma of the oral cavity. PLoS One 2014, 9(1):e84923.
10. Wu JY, Yi C, Chung HR, Wang DJ, Chang WC, Lee SY, et al. Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol 2010, 46:226-231.
11. Mehrotra R, Gupta A, Singh M, Ibrahim R Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer 2006, 5:11.
12. Mol Cancer 2012, 11:57. Retraction in.
13. Nagler RM Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol 2009, 45:1006-1010.
14. Sinha P, Mehrad M, Chernock RD, Lewis JS, El-Mofty SK, Wu N, et al. Histologic and systemic prognosticators for local control and survival in margin negative transoral laser microsurgery-treated oral cavity squamous cell carcinoma. Head Neck 2013, 10.1002/hed.23553.
15. Feng XY, Li JH, Li JZ, Han ZX, Xing RD Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma. Int J Biol Markers 2010, 25:93-98.
16. Jablonska E, Piotrowski L, Grabowska Z Serum levels of IL-1β, IL-6, TNF-α, sTNF-RI and CRP in patients with oral cavity cancer. Pathol Oncol Res 1997, 3(2):126-129.
17. Napier SS, Speight PM Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008, 37:1-10.
18. van der Waal I Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol 2010, 46:423-425.
19. Leemans CR, Braakhuis BJ, Brakenhoff RH The molecular biology of head and neck cancer. Nat Rev Cancer 2011, 11(1):9-22.
20. Hanahan D, Weinberg RA The hallmarks of cancer. Cell 2000, 100:57-70.
21. Pietras K, Ostman A Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 2010, 316:1324-1331.
22. Zimmermann BG, Wong DT Salivary mRNA targets for cancer diagnostics. Oral Oncol 2008, 44(5):425-429.
23. McIntyre GT, Oliver RJ Update on precancerous lesions. Dent Update 1999, 26(9):382-386.
24. Liotta LA, Kohn EC The microenvironment of the tumour-host interface. Nature 2001, 411:375-379.
25. Albini A, Sporn MB The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 2007, 7:139-147.
26. Shaykhiev R, Bals R Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis. J Leukoc Biol 2007, 82:1-15.
27. Balkwill F, Mantovani A Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
28. Kopfstein L, Christofori G Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 2006, 63:449-468.
29. Psaila B, Lyden D The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009, 9:285-293.
30. Suma HR, Prabhu K, Shenoy RP, Annaswamy R, Rao S, Rao A Estimation of salivary protein thiols and total antioxidant power of saliva in brain tumor patients. J Cancer Res Ther 2010, 6(3):278-281.
31. Walsh NP, Laing SJ, Oliver SJ, Montague JC, Walters R, Bilzon JL Saliva parameters as potential indices of hydration status during acute dehydration. Med Sci Sports Exerc 2004, 36:1535-1542.
32. Choo RE, Huestis MA Oral fluid as a diagnostic tool. Clin Chem Lab Med 2004, 42:1273-1287.
33. Osman TA, Costea DE, Johannessen AC The use of salivary cytokines as a screening tool for oral squamous cell carcinoma: A review of the literature. J Oral Maxillofac Pathol 2012, 16(2):256-261.
34. Navazesh M Methods for collecting saliva. Ann N Y Acad Sci 1993, 694:72-77.
35. Zhang L, Xiao H, Wong DT Salivary biomarkers for clinical applications. Mol Diagn Ther 2009, 13:245-259.
36. Berra A, Sterin-Borda L, Bacman S, Borda E Role of salivary IgA in the pathogenesis of Sjogren syndrome. Clin Immunol 2002, 104:49-57.
37. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, et al. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome. Arthritis Rheum 2007, 56:3588-3600.
38. Marchetti P, Benzi L, Masoni A, Cecchetti P, Giannarelli R, Di Cianni G, et al. Salivary insulin concentrations in type 2 (non-insulin-dependent) diabetic patients and obese non-diabetic subjects: relationship to changes in plasma insulin levels after an oral glucose load. Diabetologia 1986, 29:695-698.
39. Reilly TG, Poxon V, Sanders DS, Elliott TS, Walt RP Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests. Gut 1997, 40:454-458.
40. Castro M, Elias PC, Martinelli CE, Antonini SR, Santiago L, Moreira AC Salivary cortisol as a tool for physiological studies and diagnostic strategies. Braz J Med Biol Res 2000, 33:1171-1175.
41. Scully C HIV topic update: salivary testing for antibodies. Oral Dis 1997, 3:212-215.
42. Malamud D Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. Am J Med 1997, 102:9-14.
43. Bello PY, Pasquier C, Gourney P, Puel J, Izopet J Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies. Eur J Clin Microbiol Infect Dis 1998, 17:570-572.
44. Elsana S, Sikuler E, Yaari A, Shemer-Avni Y, Abu-Shakra M, Buskila D, et al. HCV antibodies in saliva and urine. J Med Virol 1998, 55:24-27.
45. Streckfus C, Bigler L, Dellinger T, Pfeifer M, Rose A, Thigpen JT CA 15-3 and c-erbB-2 presence in the saliva of women. Clin Oral Investig 1999, 3:138-143.
46. Bigler LR, Streckfus CF, Copeland L, Burns R, Dai X, Kuhn M, et al. The potential use of saliva to detect recurrence of disease in women with breast carcinoma. J Oral Pathol Med 2002, 31:421-431.
47. Bai J, Zhou Q, Bao ZY, Li XX, Qin M [Comparison of salivary proteins between children with early childhood caries and children without caries]. Zhonghua Kou Qiang Yi Xue Za Zhi 2007, 42:21-23. Chinese.
48. Giannobile WV, Beikler T, Kinney JS, Ramseier CA, Morelli T, Wong DT Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontol 2000 2009, 50:52-64.
49. Kinney JS, Ramseier CA, Giannobile WV Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci 2007, 1098:230-251.
50. Lee JM, Garon E, Wong DT Salivary diagnostics. Orthod Craniofac Res 2009, 12:206-211.
51. Boyle JO, Mao L, Brennan JA, Koch WM, Eisele DW, Saunders JR, et al. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 1994, 168:429-432.
52. Franzmann EJ, Schroeder GL, Goodwin WJ, Weed DT, Fisher P, Lokeshwar VB Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int J Cancer 2003, 106:438-445.
53. Yoshimura Y, Oka M, Harada T Squamous cell carcinoma-antigen for detection of squamous cell and mucoepidermoid carcinoma after primary treatment: a preliminary report. J Oral Maxillofac Surg 1990, 48:1288-1293.
54. Nagler R, Bahar G, Shpitzer T, Feinmesser R Concomitant analysis of salivary tumor markers-a new diagnostic tool for oral cancer. Clin Cancer Res 2006, 12:3979-3984.
55. Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2007, 16:1348-1355.
56. de Jong EP, Xie H, Onsongo G, Stone MD, Chen XB, Kooren JA, et al. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS One 2010, 5:e11148.
57. Arellano M, Jiang J, Zhou X, Zhang L, Ye H, Wong DT, et al. Current advances in identification of cancer biomarkers in saliva. Front Biosci (Schol Ed) 2009, 1:296-303.
58. Chen CH, Lin YS, Lin CC, Yang YH, Ho YP, Tsai CC Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients. J Oral Pathol Med 2004, 33(10):589-594.
59. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008, 14(19):6246-6252.
60. Dowling P, Wormald R, Meleady P, Henry M, Curran A, Clynes M Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J Proteomics 2008, 71(2):168-175.
61. Pickering V, Jordan RC, Schmidt BL Elevated salivary endothelin levels in oral cancer patients-a pilot study. Oral Oncol 2007, 43(1):37-41.
62. Almadori G, Bussu F, Galli J, Limongelli A, Persichilli S, Zappacosta B, et al. Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma. Head Neck 2007, 29(7):648-654.
63. Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev 2005, 29(1):42-45.
64. Katakura A, Kamiyama I, Takano N, Shibahara T, Muramatsu T, Ishihara K, et al. Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull Tokyo Dent Coll 2007, 48(4):199-203.
65. SahebJamee M, Eslami M, AtarbashiMoghadam F, Sarafnejad A Salivary concentration of TNF alpha, IL1 alpha, IL6, and IL8 in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2008, 13(5):E292-E295.
66. Tan W, Sabet L, Li Y, Yu T, Klokkevold PR, Wong DT, et al. Optical protein sensor for detecting cancer markers in saliva. Biosens Bioelectron 2008, 24(2):266-271.
67. Yamazaki Y, Chiba I, Ishikawa M, Satoh C, Notani K, Ohiro Y, et al. Serum p53 antibodies as a prognostic indicator in oral squamous cell carcinoma. Odontology 2008, 96(1):32-37.
68. Zhong LP, Chen GF, Xu ZF, Zhang X, Ping FY, Zhao SF Detection of telomerase activity in saliva from oral squamous cell carcinoma patients. Int J Oral Maxil Surg 2005, 34(5):566-570.
69. Zhong LP, Zhou XJ, Wei KJ, Yang X, Ma CY, Zhang CP, et al. [Application of serum tumor markers and support vector machine in the diagnosis of oral squamous cell carcinoma]. Shanghai Kou Qiang Yi Xue 2008, 17(5):457-460. Chinese.
70. Chen YC, Li TY, Tsai MF Analysis of the saliva from patients with oral cancer by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2002, 16(5):364-369.
71. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, nonrandomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 2005, 3:27.
72. Nakahara Y, Shintani S, Mihara M, Hino S, Hamakawa H Detection of p16 promoter methylation in the serum of oral cancer patients. Int J Oral Maxillofac Surg 2006, 35(4):362-365.
73. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004, 10(24):8442-8450.
74. Zimmermann BG, Park NJ, Wong DT Genomic targets in saliva. Ann NY Acad Sci 2007, 1098:184-191.
75. Squier CA, Kremer MJ Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 2001, 13:7-15.
76. Miller S, Sun T, Coulombe P Epidermal growth and differentiation. Fitzpatrick's dermatology in general medicine 2008, 357-383. McGraw-Hill, New York. K. Wolff, L. Goldsmith, S. Katz, B. Gilchrest, A. Paller, D. Leffell (Eds.).
77. Nanci A Oral mucosa. Ten Cate's oral histology, development structure and function 2008, 318-357. Mosby Elsevier, Missouri. A. Nanci (Ed.).
78. Feller L, Lemmer J Cancer metastasis: A short account. SADJ 2011, 66:180-183.
79. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 2009, 45:324-334.
80. Feller L, Bouckaert M, Chikte UM, Wood NH, Khammissa RA, Meyerov R, et al. A short account of cancer-specifically in relation to squamous cell carcinoma. SADJ 2010, 65:322-324.
81. Rice DH, Weimert TA Altered bacterial flora and clinical course with intraoral cancer. Laryngoscope 1978, 88:1861-1863.
82. Crean S-J, Nair SP, Fardy M, Wilson M, Spratt D Identification of bacterial DNA using PCR cloning within oral squamous cell carcinomas [abstract]. J Dent Res 2002, 81:A364.
83. Sasaki H, Ishizuka T, Muto M, Nezu M, Nakanishi Y, Inagaki Y, Watanabe H, Watanabe H, Terada M Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. Cancer Res 1998, 58:2991-2995.
84. Shiga K, Tateda M, Saijo S, Hori T, Sato I, Tateno H, et al. Presence of Streptococcus infection in extra-oropharyngeal head and neck squamous cell carcinoma and its implication in carcinogenesis. Oncol Rep 2001, 8:245-248.
85. Sakamoto H, Naito H, Ohta Y, Tanakna R, Maeda N, Sasaki J, et al. Isolation of bacteria from cervical lymph nodes in patients with oral cancer. Arch Oral Biol 1999, 44:789-793.
86. Tateda M, Shiga K, Saijo S, Sone M, Hori T, Yokoyama J, et al. Streptococcus anginosus in head and neck squamous cell carcinoma: implication in carcinogenesis. Int J Mol Med 2000, 6:699-703.
87. Krasse B The proportional distribution of Streptococcus salivarius and other streptococci in various parts of the mouth. Odontol Revy 1954, 5:203-211.
88. Gibbons RJ Bacterial adhesion to oral tissues: a model for infectious diseases. J Dent Res 1989, 68:750-760.
89. Van Houte J, Gibbons RJ, Pulkkinen AJ Adherence as an ecological determinant for streptococci in the human mouth. Arch Oral Biol 1971, 16:1131-1141.
90. Wicha MS, Liu S, Dontu G Cancer stem cells: an old idea-a paradigm shift. Cancer Res 2006, 66:1883-1890.
91. Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL Clinical implications and utility of field cancerization. Cancer Cell Int 2007, 7:2.
92. Rhiner C, Moreno E Super competition as a possible mechanism to pioneer precancerous fields. Carcinogenesis 2009, 30:723-728.
93. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 2005, 5:899-904.
94. Jameson J, Johnson B Paraneoplastic syndromes: endocrinologic/hematologic. Harrison's principles of internal medicine 2008, 617-623. McGraw-Hill, New York. D. Kasper, S. Hauser, D. Longo, J. Jameson, J. Loscaizo (Eds.).
95. Pardal R, Clarke MF, Morrison SJ Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3:895-902.
96. Fenton R, Longo D Cancer cell biology and angiogenesis. Harrison's principles of internal medicine 2008, 498-513. McGraw-Hill, New York. D. Kasper, S. Hauser, D. Longo, J. Jameson, J. Loscaizo (Eds.).
97. Lichtenstein AV On evolutionary origin of cancer. Cancer Cell Int 2005, 5:5.